Shaukat Khanum Memorial Cancer Hospital & Research Centre
Johar Town, Lahore, Pakistan Phone: +92-42-35905000, 111-155-555, Fax: 042-35945198
Email:
[email protected], Website: www.shaukatkhanum.org.pk
Department of Pathology
PDF: 05-Mar-2023 03:20:21 Special Chemistry Report Page 1 of 1
Ordered By :
Dept Ref# : 001SCH23053469
In-house Consultant :
MRNO : 001-80003371597
Report Destination : Collection Centre - Cc122
Name : SAIMA IRSHAD
Requested : 04-MAR-2023 11:50:01
Age/Sex : 45 Year(s)/Female
Specimen Received : 04-MAR-2023 15:56:43
Phone : 92 0300 8272390
Reported : 05-MAR-2023 03:12:32
Address : 443-1 C1 TOWNSHIP, LAHORE - PAKISTAN
Specimen Collected : 04-MAR-2023 11:51:22
Serology - Hepatitis
SPECIMEN : SERUM
TEST(s) RESULT(s) CUT- OFF VALUE
Anti HCV Non-Reactive Cutoff rate: 1.00
Patient Rate: 0.09
COMMENTS:
Anti HCV is a chemiluminescent microparticle immunoassay for the qualitative detection of IgG antibody to hepatitis C virus in
human serum.
This is a screening test.
If there is a non-reactive HCV Antibody result but recent HCV exposure is suspected, than do follow-up testing for HCV antibody
to demonstrate seroconversion (average of 8 to 9 weeks) and test for HCV RNA.
A non-reactive HCV Antibody result does not exclude the possibility of exposure to or infection with HCV.
Non-reactive test results in individuals with prior exposure to HCV may be due to low Antibody levels that are below the limit of
detection of this assay.
A reactive HCV antibody result indicates either current HCV infection, past HCV infection that has resolved or false reactivity. A
reactive result should be followed by HCV RNA testing. If HCV RNA is detected, that indicates current HCV infection. If HCV RNA
is not detected, that indicates either past or resolved HCV infection or false HCV antibody reactivity.
False reactive results can be obtained with heterophilic antibodies in serum, especially in patients routinely exposed to animals.
Also cross-reactivity with other viral infections and diseases is possible leading to false reactive HCV Antibody results.
Reference: Centers for Disease Control and Prevention. Testing for HCV infection: an update of guidance for clinicians and
laboratorians. MMWR Morb Mortal Wkly Rep. 2013 May 10; 62 (18): 362-5.
Please note the change in reporting practice, effective from 15 February 2023.
METHOD:
Test is performed by chemiluminescent microparticle immunoassay (CMIA) technique.
Areeba Maheen
Sr. Medical Technologist
Electronically verified report, no signature(s) required.
Dr. Asif Loya Dr. Asad Hayat Ahmad Dr. M. Tariq Mahmood Dr. Umer Nisar Sheikh
MBBS, DABP (AP and MBBS, DABP (AP, CP and MBBS, DABP (AP/CP and MBBS, DABP (AP, CP,
Cytopathology), FIAC Hematopathology) Hematopathology) Cytopathology)